Juno’s flagship cancer treatment faces new uncertainty, highlighting risks of immunotherapy by Clare McGrane on November 28, 2016November 28, 2016 at 10:55 am Juno Therapeutics announced last week that it was placing a voluntary hold on its clinical trial of JCAR015 — an experimental but promising immunotherapy treatment for patients with advanced leukemia —… Read More